Insider holders · CIK 0001316175
Anthera Pharmaceuticals Inc · ANTH
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Zenyaku Kogyo Co., Ltd.10% Owner | 2,795,895 | — | 2,795,895 | Feb 3, 2015 · 12:00 pm EST | Form 3 |
| May LiuSVP, Finance & Administration | 32,302 | — | 32,302 | Dec 23, 2015 · 6:07 am EST | Form 5 |
| Debra OdinkChief Technology Officer | 7,896 | 13,855 | 21,751 | Oct 13, 2015 · 8:02 pm EDT | Form 4 |
| Colin HislopChief Medical Officer | 19,147 | 1,897 | 21,044 | Nov 18, 2015 · 6:53 pm EST | Form 4 |
| John Craig ThompsonPresident & CEO | 19,848 | — | 19,848 | Sep 20, 2017 · 7:14 pm EDT | Form 4 |
| James PenningtonInterim Chief Medical Officer | 17,688 | — | 17,688 | Apr 5, 2016 · 1:04 pm EDT | Form 3 |
| Charles V OlsonCHIEF TECHNOLOGY OFFICER | 17,519 | — | 17,519 | Feb 6, 2017 · 6:33 pm EST | Form 5 |
| Paul F TruexDirector | 0 | 16,793 | 16,793 | Sep 7, 2017 · 6:56 pm EDT | Form 4 |
| Klara DickinsonSVP & Chief Regulatory Office | 12,500 | — | 12,500 | Jan 11, 2016 · 2:00 pm EST | Form 5 |
| Brian MuellerDirector | 10,000 | — | 10,000 | Dec 24, 2015 · 12:35 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.